| ¿µ¹® | antianginal drug | ÇÑ±Û | Ç×Çù½ÉÁõÁ¦ |
|---|---|---|---|
| ¼³¸í | Çù½ÉÁõÀº ½ÉÀ嵿¸ÆÀÇ Ç÷·ù¸¦ ÁÁ°ÔÇϰųª ½ÉÀåÀÌ Ç÷·ù¿¡ ºñÇØ¼ ¸¹Àº ÀÏÀ» ÇÏ´Â °ÍÀ» ¾ïÁ¦ÇÔÀ¸·Î½á Ä¡·áµÉ ¼ö ÀÖ´Ù. ¨ç nitrate°èÅëÀÇ ¾à¹°: Ç÷°üÀ» À̿ϽÃŰ´Â ÀÛ¿ëÀ» ÇÔÀ¸·Î½á ½ÉÀ嵿¸ÆÀÇ Ç÷·ù¸¦ ÁÁ°Ô ÇÑ´Ù. ¨è Ä®½·Åë·ÎÂ÷´ÜÁ¦(verapamil, nifedipine): ¸ðµç ±ÙÀ°ÀÇ ¼öÃà¿¡´Â CaÀÌ °ü¿©ÇÑ´Ù. Áï CaÀÌ ÀÖ¾î¾ß¸¸ ±ÙÀ°ÀÇ ¼öÃàÀÌ °¡´ÉÇØÁø´Ù. ±×·¯¹Ç·Î CaÀÌ ¼¼Æ÷¼ÓÀ¸·Î µé¾î°¡´Â °ÍÀ» ¾ïÁ¦ÇÏ´Â ¾àÁ¦´Â ±ÙÀ°ÀÇ ¼öÃàÀ» ¸·´Â´Ù. ÀÌ ¾àÀº ½ÉÀåÀÇ ±ÙÀ°¿¡ ÀÛ¿ëÇÏ¿© ½ÉÀå ±ÙÀ°ÀÇ ¼öÃàÀ» ¾ïÁ¦ÇÏ¸ç ½ÉÀåÀÌ °úµµÇÏ°Ô ÀÏÇÏ´Â °ÍÀ» ¸·°í, ¶Ç ½ÉÀ嵿¸ÆÀÇ ¼öÃà¿¡ °ü¿©ÇÏ´Â ±ÙÀ°¿¡ ÀÛ¿ëÀ» ÇÏ¿© ½ÉÀ嵿¸ÆÀ» À̿ϽÃÄѼ Ç÷·ù¸¦ ÁÁ°Ô ÇÑ´Ù. ¨é º£Å¸Â÷´ÜÁ¦(beta-blocker): ½ÅüÀÇ ¿îµ¿·®À̳ª ±âŸÀÇ ¿ä±¸¿¡ ÀÇÇØ¼ ½ÉÀåÀ» »¡¸® ¶Ù°ÔÇÏ´Â ½Å°æÀº ¹Ù·Î º£Å¸-±³°¨½Å°æÀÌ´Ù. ±³°¨½Å°æ°è¶õ »ç¶÷ÀÌ À§±ÞÇÑ »óȲ¿¡¼ ÀÛ¿ëÇÏ´Â ÀÚÀ²½Å°æ°èÀÌ´Ù. Áï »ç¶÷ÀÌ ±äÀåÇϰųª ½Î¿ï °æ¿ì¿¡ ÀüÇüÀûÀ¸·Î ±³°¨½Å°æ°è°¡ ÀÛ¿ëÇÑ´Ù. Áï ½ÉÀåÀÌ ¶Ù°Å³ª ¼ÒȰ¡ ¾ÊµÇ°Å³ª µ¿°øÀÌ Ä¿Áö´Â °Í µûÀ§°¡ ¹Ù·Î ±³°¨½Å°æ°èÀÇ ¿ªÇÒÀ̶ó°í ÇÒ ¼ö ÀÖ´Ù. ÀÌ ±³°¨½Å°æ°è¿¡¼ ¸»ÃÊÀå±â¿¡ º¸³»´Â ½Å°æÀÌ ±³°¨½Å°æÀÌ´Ù. ±×·¯¹Ç·Î ½ÉÀå¿¡¼ ½ÉÀåÀ» ½Åü¿¡ Çʿ信 µû¶ó¼ ¸¹Àº ÀÏÀ» ÇϰÔÇÏ´Â ½Å°æÀ» Â÷´ÜÇÒ °æ¿ì¿¡´Â Çù½ÉÁõÀ» Ä¡·áÇÒ ¼ö ÀÖ°Ô µÈ´Ù(½ÉÀåÀÇ »ê¼Ò³ª ±âŸ ¿µ¾çºÐÀÇ ¼ö¿ä¸¦ ÁÙÀδÙ). |
||
| ¿µ¹® | obsessive-compulsive disorder | ÇÑ±Û | °¹Ú¹ÝÀÀ¼º Àå¾Ö |
|---|---|---|---|
| ¼³¸í | °¹Ú»ç°í(obsession)Àº ¹Ýº¹µÇ´Â »ç°í¸¦ ¸»Çϸç, °¹ÚÇàÀ§(compulsion)´Â ¹Ýº¹µÇ´Â ÇൿÀ» ¸»ÇÑ´Ù. Áï ¹Ýº¹µÇ´Â »ç°í¿¡ µû¶ó ¹Ýº¹ÀûÀÎ ÇൿÀ» ¼öÇàÇÏ´Â Àå¾Ö¸¦ ¸»ÇÑ´Ù. À̶§ ¹Ýº¹ÀûÀÎ »ç°í´Â ÀÌ·ÐÀûÀ¸·Î ÀÌÇØµÇÁö ¾Ê´Â °æ¿ì°¡ ¸¹°í, º»Àεµ ÀÌ·± »ç°í°¡ ÀÌÇØµÇÁö ¾Ê´Â´Ù´Â »ç½ÇÀ» ¾Ë°í °íÄ¡·Á°í ÇÏÁö¸¸, Àß µÇÁö ¾Ê´Â´Ù. ¶ÇÇÑ °è¼ÓÀûÀ¸·Î ÀÌ·± »ç°í¿¡ µû¸¥ ¹Ýº¹ÀûÀÎ ÇൿÀ» Çϸç, ÀÌ·± ÇൿÀ» ¼öÇàÄ¡ ¾ÊÀ» ½Ã, º»ÀÎÀÇ ÀÇÁö¿Í ¹«°üÇÏ°Ô ¸÷½Ã ºÒ¾ÈÇØÇϰí, ÃÊÁ¶ÇØÇÑ´Ù. |
||
| ¿µ¹® | panic disorder | ÇÑ±Û | °øÈ²Àå¾Ö |
|---|---|---|---|
| ¼³¸í | ¹Ýº¹µÇ´Â °øÈ²¹ßÀÛ(panic attack: °©ÀÛ½º·± °øÆ÷»óÅÂÀÇ ¹ßº´)°ú ½Å°æ°ú¹ÎÀ» ³ªÅ¸³»´Â °æ¿ì¸¦ ¸»ÇÔ. °øÈ²¹ßÀÛÀº ´Üµ¶À¸·Î ÀϾ±âº¸´Ù´Â ¿À·£ ±äÀå»óÅ¿¡¼ ÁÖ±âÀûÀ¸·Î ÀϾ´Â Çö»óÀ¸·Î º¸ÀδÙ. °øÈ²¹ßÀÛÀÇ Áõ»óÀº ±Þ°ÝÇÑ ÀÚÀ²½Å°æÀÚ±ØÁõ»óÀ¸·Î È£Èí°ï¶õ, ½ÉÀå¹Úµ¿Ç×Áø, ÈäºÎÅëÁõ, ÈäºÎ¾Ð¹Ú°¨, Áú½Ä°¨, Çö±âÁõ, ºÒ¾ÈÁ¤ÇÑ ´À³¦ µîÀÌ´Ù. ´ë°³ °©ÀÚ±â ÀϾ ¼öºÐµ¿¾È Áö¼ÓÇß´Ù°¡ ¼Ò½ÇµÇ´Â °ÍÀÌ º¸ÅëÀÌ´Ù. µå¹°°Ô´Â ¼ö½Ã°£ Áö¼ÓµÇ±âµµ ÇÑ´Ù. °øÈ²¹ßÀÛÀº ÁÖ±âÀûÀ¸·Î ¹Ýº¹µÇ¸é¼ ¸¸¼ºÈÇÏ´Â °æÇâÀÌ ¸¹´Ù. ½Å°æ°ú¹ÎÀº °øÈ²¹ßÀÛÀÌ ¾ø´Â ½Ã±âÀÇ Áõ»óÀÌ´Ù. °¨´çŰ ¾î·Á¿î °øÈ²¹ßÀÛ¿¡ ´ëÇÑ ¿¹±âºÒ¾È(±× ÀÏÀÌ ÀϾÁö ¾ÊÀ»±î ÇÏ´Â ´À³¦ ¶§¹®¿¡ ¿À´Â ºÒ¾È)ÀÌ ÀÖ°í ±× ¶§¹®¿¡ Á¶½É½º·¯¿öÁö°í ÁÖÀ§¸¦ »ìÇǴ ŵµµµ ³ªÅ¸³ª¼ ½Å°æÀº ±Øµµ·Î ³¯Ä«·Î¿öÁø´Ù. °øÆ÷Àå¾Ö¿¡¼µµ ÀÌ·± °øÈ²¹ßÀÛÀÌ ¿Ã ¼ö ÀÖÀ¸³ª, ÀÌ °æ¿ì´Â Ưº°ÇÑ ´ë»óÀ̳ª »óȲÀÌ ÀÖ´Â °Í¿¡ ¹ÝÇØ °øÈ²Àå¾Ö´Â ÀÌ·± Ưº°ÇÑ »ç°Ç¾øÀÌ ÁÖ±âÀûÀ¸·Î ¹ß»ýÇÑ´Ù. Ä¡·á´Â Ç׺ҾÈÁ¦¿Í ¶§·Î´Â Ç׿ì¿ïÁ¦¸¦ »ç¿ëÇÑ´Ù. |
||
| ¿µ¹® | antisocial personality disorder | ÇÑ±Û | ¹Ý»çȸÀûÀΰÝÀå¾Ö |
|---|---|---|---|
| ¼³¸í | Áö¼ÓÀûÀ¸·Î ±×¸®°í ¸¸¼ºÀûÀ¸·Î ¹Ý»çȸÀûÀÎ ÇൿÀ» ÇÏ´Â Á¤½Å°úÀû º´. ´Ù¸¥ »ç¶÷¿¡°Ô Áø½Ç¼ºÀÌ ¾ø°í ´Ù¸¥ »ç¶÷ÀÇ ±Ç¸®³ª ÇÇÇØ¿¡´Â ÀüÇô ¹«°¨°¢ÇÏ°í ´ÜÁö ÀÚ½ÅÀÇ Ãæµ¿°ú ¿å±¸¿¡ ÀÇÇØ¼ ÇൿÀ» ÇÑ´Ù. ÀÚ½ÅÀÇ ½Ç¼ö¿¡ ´ëÇØ¼ ´Ù¸¥ »ç¶÷ÀÌ Ãæ°íÇÏ´Â °ÍÀ» ÂüÁö¸øÇϰí Ç×»ó ÀÚ½ÅÀÇ ¸¶À½´ë·Î¸¸ ÇÑ´Ù. |
||
| ¿µ¹® | anxiety disorder | ÇÑ±Û | ºÒ¾ÈÀå¾Ö |
|---|---|---|---|
| ¼³¸í | ½É¸®Àû ºÒ¾ÈÁ¤À̳ª ºÒ¾È µîÀ» ÁÖ Æ¯Â¡À¸·Î ÇÏ´Â Á¤½Å°úÀû º´ÅÂ. ´ëÇ¥ÀûÀÎ ¿¹·Î´Â °øÆ÷Áõ(phobia)¿Í °øÈ²Àå¾Ö(panic disorder), Àü¹ÝÀû ºÒ¾ÈÀå¾Ö(generalized anxiety disorder) µîÀÌ ÀÖ´Ù. °øÆ÷ÁõÀ̶õ ƯÁ¤ÇÑ Àå¼Ò³ª »óȲ¿¡ ´ëÇØ¼ º´ÀûÀÎ ºÒ¾ÈÀ» ´À³¢´Â °ÍÀ¸·Î ±¤Àå°øÆ÷Áõ(agoraphobia): Ź Æ®ÀÎ °ø°£À» ¹«¼¿öÇÔ. »çȸ°øÆ÷Ãþ(social phobia): ´Ù¸¥ »ç¶÷¾Õ¿¡ ¼´Â °ÍÀ» ¹«¼¿ö ÇÔ. °í¼Ò°øÆ÷Ãþ(acrophobia): ³ôÀº °÷¿¡ °¡´Â °ÍÀ» ¹«¼¿öÇÔ. ÁøÆó°øÆ÷Áõ(claustrophobia): ¹ÐÆóµÈ °ø°£À» ¹«¼¿öÇÔ. µ¿¹°°øÆ÷Áõ(zoophobia): µ¿¹°À» º´ÀûÀ¸·Î ¹«¼¿öÇÔ µîÀ» Æ÷ÇÔÇÑ´Ù. °øÈ²Àå¾Ö(panic disorde)¶õ ¿ÜºÎÀÇ À§ÇèÇÑ ÀÚ±ØÀÌ ¾ø´Âµ¥µµ ºÒ±¸ÇÏ°í °©Àڱ⠱ؽÉÇÑ °øÆ÷¸¦ ´À³¢´Â °ÍÀ» ¸»ÇÑ´Ù. ´ë°³ ½ÉÀåÀÌ ½ÉÇÏ°Ô ¶Ù°Å³ª ½ÄÀº ¶¡À» È긮°í, ½Ç½Å, È£Èí°ï¶õ µîÀÇ Áõ»óÀ» µ¿¹ÝÇÑ´Ù. Àü¹ÝÀû ºÒ¾ÈÀå¾Ö(generalized anxiety disorder)¶õ 1°³¿ùÀÌ»ó Áö¼ÓÀûÀÎ ºÒ¾ÈÀ» ´À³¢´Â °ÍÀ» ¸»ÇÑ´Ù. ´ë°³ »ç¼ÒÇÑ ÀÏ»óÀÇ ÀÏ¿¡ ´ëÇÑ ºÒ¾ÈÀ» ´À³¢¸ç, ºÒ¾ÈÀÇ ´ë»óÀÌ ¾ø´Â °æ¿ì¿¡´Â ¾ðÁ¦ ºÒ¾ÈÀ» ´À³¥Áö ¸ð¸¥´Ù´Â ºÒ¾È°¨(¿¹±âºÒ¾È)À» È£¼ÒÇÑ´Ù. ´ë°³ ¼è¾à, ¾îÁö·¯¿ò, ¼Õ¶³¸², ¶¡À» È긮´Â µîÀÇ ½ÅüÀû Áõ»óÀ» µ¿¹ÝÇÑ´Ù. |
||
| BD | barbital-dependent; barbiturate dependence; base deficit; base of prism down; basophilic degeneratio... |
|---|---|
| PAD | pain and distress; patient surface axis depth; percutaneous abscess drainage; percutaneous automated... |
| SPD | schizotypal personality disorder; sociopathic personality disorder; specific paroxysmal discharge; s... |
| ICD | I-cell disease; immune complex disease; implantable cardioverter defibrillator; impulse-control diso... |
| PIXE | particle-induced x-ray emission; proton-induced x-ray emission |
| alpha-chymotrypsin-induced glaucoma | Transient secondary glaucoma following the use of alpha-chymotrypsin in cataract extraction. (05 Mar 2000) |
|---|---|
| antibiotic induced enteritis | <pathology> A condition where the normal intestinal bacteria (useful for digestion) are killed by the use of an antibiotic resulting in symptoms. (27 Sep 1997) |
| antibiotic induced gastroenteritis | <pathology> A condition where the normal intestinal bacteria (useful for digestion) are killed by the use of an antibiotic resulting in symptoms. (27 Sep 1997) |
| antibody induced lysis | <haematology> The term is imprecise and should not be used since there is confusion as to which mechanism is involved, i.e. Natural killing or complement lysis. See: complement lysis, natural killer cells. (09 Feb 1998) |
| asthma, exercise-induced | Asthma attacks following a period of exercise. Usually the induced attack is short-lived and regresses spontaneously. The magnitude of postexertional airway obstruction is strongly influenced by the environment in which exercise is performed (i.e. Inhalation of cold air during physical exertion markedly augments the severity of the airway obstruction; conversely, warm humid air blunts or abolishes it). (12 Dec 1998) |
| bacteriophage T7 induced DNA polymerase | <enzyme> Complex of two proteins, phage gene 5 protein and E coli thioredoxin Registry number: EC 2.7.7.- Synonym: t7 phage DNA polymerase, sequenase, t7 DNA polymerase, thermo sequenase (26 Jun 1999) |
| carbohydrate-induced hyperlipaemia | type III familial hyperlipoproteinaemia, type IV familial hyperlipoproteinaemia |
| combined fat-and carbohydrate-induced hyperlipaemia | Hyperlipoproteinaemia characterised by increased plasma levels of chylomicrons, VLDL, pre-beta-lipoproteins, and triglycerides, and slight rise of cholesterol on a normal diet, with beta-lipoproteins normal; may be accompanied by bouts of abdominal pain, hepatosplenomegaly, susceptibility to atherosclerosis, and abnormal glucose tolerance; probably autosomal recessive inheritance. Synonym: combined fat-and carbohydrate-induced hyperlipaemia, familial hyperchylomicronaemia with hyperprebetalipoproteinaemia, mixed hyperlipaemia. (05 Mar 2000) |
| contact induced spreading | The response in which contact between two epithelial cells leads to a stabilised contact and the increased spreading of the cells so that the area covered is greater than that covered by the two cells in isolation. (18 Nov 1997) |
| corticosteroid-induced acne | The exacerbation of acne after corticosteroid use is a common drug reaction seen in adolescents. Lessening the dose of the corticosteroid will often diminish this effect. (27 Sep 1997) |
| corticosteroid-induced glaucoma | <ophthalmology> Glaucoma caused by a hereditary predisposition in which local instillation of eyedrops containing corticosteroid causes increased intraocular pressure. (05 Mar 2000) |
| corticosteroid-induced striae | <dermatology> High-dose glucocorticoid therapy causes atrophy of the skin and a failure of the normal regenerative process. Purple striae often develop over the individual's trunk or thighs. The colour fades when the drug is stopped, but the dermal atrophy remains. (27 Sep 1997) |
| hearing loss, noise-induced | Hearing loss from exposure to noise. The loss is often in the frequency range 4000-6000 hertz. (12 Dec 1998) |
| heart arrest, induced | Arrest of the contraction of the myocardium by the use of cardioplegic chemical compounds (cardioplegic solutions) or of cold during heart surgery. (12 Dec 1998) |
| SA-induced protein kinase | <enzyme> 48-kD map kinase isolated from nicotiana tabacum; genbank u94192 Registry number: EC 2.7.10.- Synonym: p48 sip kinase, salicylic acid-induced protein kinase, sipk enzyme (26 Jun 1999) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|